Late-onset spondyloarthritis is an emerging clinical challenge that complicates standard diagnostic criteria, as current frameworks largely focus on patients under age 45. While medical guidelines from the Assessment of SpondyloArthritis international Society (ASAS) effectively identify younger patients, a 57-year-old patient treated at Calmette Hospital in April 2026 demonstrates that inflammatory rheumatic disease can manifest significantly later in life, often leading to delayed diagnosis and treatment.
Why Does the Age-at-Onset Criterion Matter?
The current ASAS classification criteria for axial spondyloarthritis are restricted to patients with symptom onset before age 45. According to researchers at Calmette Hospital, this age-based threshold creates a diagnostic blind spot. Because clinicians are trained to look for these conditions in young adults, older patients with persistent inflammatory back pain may be misdiagnosed or suffer for years without targeted therapy. Data cited by Olivieri et al. indicates that approximately 3.5% to 6% of axial spondyloarthritis patients experience disease onset after age 45, suggesting that the current “young adult” focus may be too narrow to capture the full patient population.
The 57-year-old patient featured in the Calmette Hospital case study initially managed her symptoms with over-the-counter painkillers for two years before receiving a rheumatologic evaluation. This delay is common in late-onset cases where the disease is not suspected.
How Is Late-Onset Spondyloarthritis Diagnosed?
Diagnosis in older adults relies on identifying classic inflammatory markers through imaging and clinical history, even when the patient falls outside typical age demographics. In the 2026 Calmette Hospital case, clinicians utilized MRI imaging to confirm active sacroiliitis, characterized by bone marrow edema. This imaging, paired with inflammatory buttock pain and elevated C-reactive protein (CRP) levels, met the diagnostic threshold. Other researchers, such as Voulgari et al., have noted that diagnosing these cases often requires an exhaustive process of exclusion, particularly when patients present with non-specific symptoms like fever or malaise rather than classic back stiffness.
What Are the Risks of Misdiagnosis in Elderly Patients?
Misdiagnosis in older patients can lead to unnecessary surgeries or the progression of joint damage. For example, Chung et al. documented a 66-year-old man who underwent bilateral total hip replacements for “unexplained” arthritis before his underlying spondyloarthritis was identified. Unlike younger patients, older adults often present with complex comorbidities, such as the type 2 diabetes and hypertension reported in the Calmette Hospital case, which can complicate the clinical picture. When clinicians ignore the possibility of spondyloarthritis due to age, patients may be subjected to ineffective treatments that fail to address the underlying systemic inflammation.
Comparison of Clinical Presentations
| Source Case | Primary Symptoms | Key Finding |
|---|---|---|
| Calmette Hospital (2026) | Inflammatory buttock pain | Sacroiliitis on MRI |
| Chung et al. | Knee and ankle swelling | HLA-B27 positive |
If you are experiencing chronic, inflammatory-style back pain that improves with movement, do not assume it is strictly an “age-related” issue. Consult a rheumatologist to discuss whether MRI imaging is warranted, regardless of your age.
Frequently Asked Questions
Can spondyloarthritis start after age 50?
Yes. While it is rare, late-onset spondyloarthritis is an recognized clinical entity. Studies suggest it accounts for up to 6% of cases, though it is often under-recognized due to the age-restricted nature of current classification criteria.
What is the most reliable way to diagnose this in older adults?
Diagnosis usually involves a combination of clinical history—such as morning stiffness and pain improvement with exercise—and imaging, specifically MRI of the sacroiliac joints, which can reveal active inflammation even when X-rays appear normal.
Why is HLA-B27 testing not always definitive?
HLA-B27 is a genetic marker associated with the disease, but as noted in the Calmette Hospital case, it is not always available or necessary for diagnosis if other clinical and imaging criteria are met.
Have you or a family member experienced persistent joint pain that was difficult to diagnose? Share your questions in the comments below or subscribe to our newsletter for the latest updates on rheumatological health research.